-
An IRB member and human research protection expert learned firsthand how complicated informed consent (IC) forms could be when her granddaughter was seriously ill.
-
The exponential increase in smartphones and social networking sites has led to concerns from some patients regarding the possible unlawful distribution of images outside the realms of their care.
-
The Cincinnati Childrens Hospital Medical Center IRB and a special task force developed guidance and a template for improving and simplifying informed consent forms.
-
As technology in genetic and genomic research expands, most if not all IRBs will face the issue of incidental findings, including how to manage them, and whether researchers have a duty to report them to study participants, experts say.
-
There are no industry standards for handling incidental findings (IFs) in research.
-
IRBs often struggle with determining risks of social and behavioral research studies. Its easy to be both too cautious and too complacent.
-
Health care providers frequently have misconceptions about legal requirements of end-of-life care. By educating providers about how to make decisions when people lose capacity, fewer formal ethics or legal consults will be needed.
-
The Affordable Care Act invested significantly in comparative effectiveness research (CER), but at the same time, states that no decisions coming out of CER should determine what treatments are covered by insurers, notes Norman Daniels, PhD, professor of ethics and population health at Harvard School of Public Health in Boston, MA.
-
While the vast majority of gamete donations are made anonymously, a growing number of countries are enacting laws allowing children access to identifying information about their gamete donor.
-
Consumer Reports has released safety scores for U.S. hospitals by combining five key measures into one composite score from 1 to 100.